Long-term treatment with trastuzumab of patient with skin metastatic breast cancer - a case report

被引：0
|
作者：
Zygulska, Aneta L. [1 ]
Krzemieniecki, Krzysztof [2 ]
机构：
[1] Szpitala Uniwersyteckiego Krakowie, Klin Onkol, Krakow, Poland
[2] Uniwersytetu Jagiellonskiego Krakowie, Klin Onkol, Coll Med, Krakow, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2010年 / 6卷 / 03期
关键词：
metastatic breast cancer; trastuzumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Trastuzmab is the treatment of choice for HER2-overexpressing metastatic breast cancer. The treatment is well tolerated. Despite the fact that trastuzumab is used commonly, duration of the treatment has not been defined. Case of 46-year old female patient on continuous 5 year trastuzumab was described.
引用
收藏
页码：113 / 115
页数：3
相关论文
共 50 条
  • [31] Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report
    Sano, Masayuki
    Yamamoto, Shinya
    Uehara, Sho
    Yuasa, Takeshi
    Masuda, Hitoshi
    Fukui, Iwao
    Yonese, Junji
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (03) : 208 - 210
  • [32] Cardiotoxicity Related to Long-Term Trastuzumab Therapy in Metastatic Breast Cancer: The Potential Role of Treatment Duration and Cardiac Risk Factors
    Pistilli, Barbara
    Marcellusi, Andrea
    Latini, Luciano
    Accardi, Roberto
    Ferretti, Benedetta
    Benedetti, Giovanni
    BREAST JOURNAL, 2015, 21 (03): : 318 - 321
  • [33] Complete response and long-term survival to endocrine monotherapy in a patient with metastatic breast cancer in a low-income country: a case report
    Sada, Raghad
    Karim, Nouralhuda
    Rohaibani, Ghina
    Alali, Mousa
    Saifo, Maher
    JOURNAL OF MEDICAL CASE REPORTS, 2024, 18 (01)
  • [34] Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: Impact of institutions
    Fiteni, Frederic
    Villanueva, Cristian
    Bazan, Fernando
    Perrin, Sophie
    Chaigneau, Loic
    Dobi, Erion
    Montcuquet, Philippe
    Cals, Laurent
    Meneveau, Nathalie
    Nerich, Virginie
    Limat, Samuel
    Pivot, Xavier
    BREAST, 2014, 23 (02): : 165 - 169
  • [35] Long-term responders to trastuzumab among patients with HER2-positive metastatic breast cancer
    Barriere, J.
    Mari, V.
    Follana, P.
    Largillier, R.
    Chamorey, E.
    Lescaut, W.
    Flipo, B.
    Ettore, F.
    Raoust, I.
    Peyrottes, I.
    Figl, A.
    Marcy, M.
    Ihrai, T.
    Courdi, A.
    Ferrero, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Long-term survival in a patient with multiple metastatic gastric cancer treated with PTX plus emvolimab and disitamab vedotin: case report and treatment experience: A case report
    Zhou, Yongjin
    Zhang, Meifeng
    Dai, Li
    Yan, Zhiqiang
    Wang, Haibin
    Yang, Hongxin
    Jin, Xiangren
    Wang, Qian
    MEDICINE, 2024, 103 (03) : E36927
  • [37] Long-term Treatment with Intravenous Bisphosphonates in Metastatic Breast Cancer: A Retrospective Study
    Brufsky, Adam M.
    Sereika, Susan M.
    Mathew, Aju
    Tomifumi, Onishi
    Singh, Vikramjit
    Rosenzweig, Margaret
    BREAST JOURNAL, 2013, 19 (05): : 504 - 511
  • [38] Ziconotide in the Treatment of Neuropathic Pain in a Patient with Metastatic Breast Cancer: A Case Report
    Eldabe, S.
    Brookes, M.
    3RD INTERNATIONAL CONGRESS ON NEUROPATHIC PAIN (NEUPSIG), 2010, : 157 - 159
  • [39] Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: The M.D. Anderson Cancer Center experience
    Guarneri, Valentina
    Lenihan, Daniel J.
    Valero, Vicente
    Durand, Jean-Bernard
    Broglio, Kristine
    Hess, Kenneth R.
    Michaud, Laura Boehnke
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) : 4107 - 4115
  • [40] Long-term treatment of patient with metastatic melanoma of the trunk
    Kempa-Kaminska, Natasza
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 : A19 - A22
12345